Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (<i>RET</i> Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.

Zhang, Shannon S; Ou, Sai-Hong Ignatius

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.

Zhang, Shannon S; Ou, Sai-Hong Ignatius.

Afiliação

Zhang SS; Department of Medicine, University of California, Irvine School of Medicine, Orange, California.
Ou SI; Department of Medicine, University of California, Irvine School of Medicine, Orange, California.

JTO Clin Res Rep ; 3(8): 100358, 2022 Aug.

Article em En | MEDLINE | ID: mdl-36046400

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422432
https://dx.doi.org/10.1016/j.jtocrr.2022.100358

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422432
https://dx.doi.org/10.1016/j.jtocrr.2022.100358

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article